Terumo Corporation

4543.T
Medical Instruments & Supplies
2026/01/16 Updated
Market Cap: $20.8B (¥3.3T)
Stock Price: $14.13 (¥2,240)
Exchange Rate: 1 USD = ¥158.48

Stock Price Chart

2026/01/16 Updated
25.32
PER (Price Earnings Ratio)
vs Industry Avg: +15.8
2.30
PBR (Price to Book Ratio)
vs Industry Avg: +1.0
1.34%
Dividend Yield
vs Industry Avg: -1.61%

Price Trend

2026/01/16 Updated
Short-term
5-Day MA
-1.20%
Near-term
25-Day MA
-2.54%
Mid-term
75-Day MA
-7.07%
Long-term
200-Day MA
-12.12%

Price & Trading Details

2026/01/16 Updated

PRICE

Previous Close ¥2,278
Open ¥2,284
High ¥2,290
Low ¥2,235
Close ¥2,240

TRADING

Volume 8,530,300
Average Volume 4,311,057
Turnover ¥191億
Min. Purchase ¥224,000

Analyst Recommendations 14 analysts

Updated 2026/01/11
Strong Buy
2
2
Buy
9
9
Hold
3
3
Sell
0
Strong Sell
0
Target Price (Mean)
¥3,101
None
¥3,700
High
¥3,200
Median
¥2,500
Low
+33% vs Current Price
This information is based on market data from third-party data providers and is for reference only. Investment decisions are your own responsibility.

Shareholder Composition

Updated 2026/01/11
2.6%
Insider Holdings
57.5%
Institutional
40.0%
Public Float
371
Institutional Holders
Insider Holdings 2.6%
Institutional 57.5%
Public Float 40.0%

Top Mutual Funds / ETFs

Updated 2026/01/11

Major Holders

Updated 2026/01/11
Fund Name Ownership Shares Change
VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund
1.41%
20.8M +0.15%
VANGUARD TAX-MANAGED FUNDS-Vanguard Developed Markets Index Fund
0.90%
13.3M +2.50%
MFS Series Trust XVII-MFS International Equity Fund
0.88%
13.0M +5.41%
iShares Trust-iShares Core MSCI EAFE ETF
0.61%
9.1M +1.38%
MFS SERIES TRUST X-MFS International Growth Fund
0.57%
8.4M +4.34%
BNY Mellon Strategic Funds, Inc.-BNY Mellon International Stock Fund
0.41%
6.0M 0.00%
Institution Ownership Shares Change
Boston Common Asset Management, LLC
0.01%
90.6K -2.05%
Pacer Advisors, Inc.
<0.01%
15.3K +0.52%

Dividend History 4Years Growth

Updated 2026/01/11
-%
Dividend Yield
¥28
Annual Dividend
+16.7%
YoY Growth
35.4%
Payout Ratio
Year Dividend Change
2025 ¥28 +16.7%
2024 ¥24 +11.6%
2023 ¥22 +16.2%
2022 ¥19 +23.3%
2021 ¥15 -

Financial Performance

2026/01/11 Updated

Revenue & Profit

Margins

Cash Flow

Financial Health

2022 2023 2024 2025
Income Statement
Revenue ¥703,303M ¥820,209M ¥921,863M ¥1,036,171M
Gross Profit ¥369,341M ¥417,369M ¥479,174M ¥560,670M
Operating Income ¥115,960M ¥117,333M ¥140,095M ¥157,670M
Pretax Income ¥117,462M ¥120,153M ¥143,604M ¥160,821M
Net Income ¥88,813M ¥89,325M ¥106,374M ¥116,978M
EPS ¥58.69 ¥59.48 ¥71.47 ¥78.99
Operating Margin 16.49% 14.31% 15.20% 15.22%
Balance Sheet
Total Assets ¥1,473,693M ¥1,602,225M ¥1,831,402M ¥1,828,393M
Total Equity ¥1,012,313M ¥1,111,063M ¥1,327,090M ¥1,368,535M
Total Liabilities ¥461,380M ¥491,162M ¥504,312M ¥459,858M
Cash ¥205,251M ¥187,322M ¥204,883M ¥221,872M
Interest-bearing Debt ¥225,996M ¥231,937M ¥231,848M ¥174,838M
Equity Ratio 68.69% 69.35% 72.46% 74.85%
D/E Ratio 0.22 0.21 0.17 0.13
Cash Flow
Operating CF ¥141,467M ¥117,536M ¥146,330M ¥210,802M
Investing CF -¥78,454M -¥59,121M -¥81,472M -¥82,481M
Financing CF -¥70,879M -¥86,559M -¥62,079M -¥108,766M
Free CF ¥67,362M ¥45,363M ¥67,556M ¥128,437M
Efficiency
ROE 8.77% 8.04% 8.02% 8.55%
ROA 6.03% 5.58% 5.81% 6.40%

Latest IR Information

  • No IR information found for this company.

    Searched stock code: 4543

Company Information

English Name Terumo Corporation
Japanese Name テルモ(株)
Stock Code 4543.T (JPX)
Sector / Industry Healthcare / Medical Instruments & Supplies

About

Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. It operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company. The Cardiac and Vascular Company segment offers angiographic guidewires, angiographic catheters, introducer sheaths, vascular closure devices, PTCA balloon catheters, coronary stents, self-expanding peripheral stents, intravascular ultrasound systems, imaging catheters, and others; coils, stents, and intrasaccular devices for treating cerebral aneurysm; embolization systems, aspiration catheters, and clot retrievers for treating ischemic stroke and others; oxygenators, cardio-pulmonary bypass systems, and others; and artificial vascular stent grafts, and others. The Medical Care Solutions Company segment provides syringes, infusion pumps, syringe pumps, infusion lines, I.V. solutions, peritoneal dialysis fluids, pain management adhesion barriers, and others; blood glucose monitoring systems, disposable needles for pen-injector, insulin patch pumps, blood pressure monitors, digital thermometers, and others; and contract manufacturing of prefilled syringes, devices to pharmaceutical companies for use in drug kits, such as prefillable syringes, needles for pharmaceutical packaging business, and others. The Blood and Cell Technologies Company segment offers blood bags, component collection systems, automated blood processing systems, pathogen reduction systems, centrifugal apheresis systems, cell expansion systems, and others. The company was formerly known as Sekisen Ken-onki Corporation and changed its name to Terumo Corporation in October 1974. Terumo Corporation was incorporated in 1921 and is headquartered in Tokyo, Japan.

Data provided by Yahoo Finance